NCT05431075View on ClinicalTrials.gov

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

PHASE4CompletedINTERVENTIONAL
Enrollment

406

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Amoxicillin

Included in quadruple eradication medication.

DRUG

Tetracycline tid

Included in quadruple eradication medication.

DRUG

Tetracycline qid

Included in quadruple eradication medication.

DRUG

Bismuth Potassium Citrate

Included in quadruple eradication medication.

DRUG

Colloidal Bismuth Pectin

Included in quadruple eradication medication.

DRUG

Esomeprazole 20mg

Included in quadruple eradication medication.

Trial Locations (6)

257000

Qilu hosipital, Jinan

Unknown

Zhengzhou Central Hospital, Zhengzhou

Taierzhuang District People's Hospital, Taierzhuang

Yuncheng Hospital of Traditional Chinese Medicine, Yuncheng

PKUCare Luzhong Hospital, Zibo

Zibo Central Hospital, Zibo

All Listed Sponsors
collaborator

Peking University Care Luzhong Hospital

OTHER

collaborator

Yuncheng Traditional Chinese Medicine Hospital

OTHER

collaborator

Taierzhuang District People's Hospital

OTHER

collaborator

Zhengzhou Central Hospital

OTHER

collaborator

Zibo Central Hospital

OTHER_GOV

lead

Shandong University

OTHER